Clinical Trials Browser

Glioblastoma

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma

Astrocytoma, Glioblastoma, Glioma

Paraganglioma, Pheochromocytoma

Neoplasm Metastasis, Sarcoma, Ewing

Neuroectodermal Tumors, Primitive, Pyloric Stenosis, Hypertrophic

Somatostatinoma, Carcinoma, Neuroendocrine

Lung Neoplasms, Small Cell Lung Carcinoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Gastrointestinal Stromal Tumors

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Neuroblastoma

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Colorectal Adenocarcinoma

Brain Neoplasms, Glioblastoma

Adenoma, Islet Cell

Glioblastoma

Colorectal Neoplasms, Microsatellite Instability

Advanced Melanoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Ependymoma, Medulloblastoma, Recurrence

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Neuroblastoma

Neuroblastoma

Glioblastoma

Ependymoma, Medulloblastoma

Glioblastoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Glioblastoma

Glioblastoma

Primary Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Neuroblastoma

Leiomyosarcoma, Sarcoma

Glioblastoma

Brain Neoplasms, Glioblastoma

Clinical Trials

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

PNOC031

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

GIST

Pan Tumor Rollover Study

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

CAMPFIRE

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

ARETHUSA

A Phase II Trial of LM103 in Advanced Melanoma

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

MEMMAT

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

2-THE-TOP

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

ARISTOCRAT

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

MATVAC-1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Newly Diagnosed Glioblastoma

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma